EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+13.43%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$219M
AUM Growth
+$219M
(-12%)
Cap. Flow
-$13.4M
Cap. Flow
% of AUM
-6.11%
Top 10 Holdings %
Top 10 Hldgs %
75.45%
Holding
43
New
7
Increased
6
Reduced
10
Closed
9
Top Buys
| 1 |
Galapagos
GLPG
|
$10.7M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$9.51M |
| 3 |
DERM
Dermira, Inc.
DERM
|
$7.96M |
| 4 |
Intellia Therapeutics
NTLA
|
$6.63M |
| 5 |
AKAO
Achaogen, Inc.
AKAO
|
$5.96M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$20.3M |
| 2 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$10.5M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$8.64M |
| 4 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$7.07M |
| 5 |
KITE
Kite Pharma, Inc.
KITE
|
$6.89M |
Sector Composition
| 1 | Healthcare | 90.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ironwood Pharmaceuticals
IRWD
$214M
| $31.8M | 12.53% | 2,430,451 +369,034 | +18% | +$4.83M |
|
|
2
Galapagos
GLPG
$2.07B
| $24.4M | 9.61% | 439,385 +192,694 | +78% | +$10.7M |
|
3
Travere Therapeutics
TVTX
$1.56B
| $21.8M | 8.6% | 1,225,084 | – | – |
|
4
Cytokinetics
CYTK
$4.23B
| $20.3M | 8.01% | 2,139,697 +86,897 | +4% | +$825K |
|
5
Assembly Biosciences
ASMB
$190M
| $16.3M | 6.44% | 2,943,164 +844,862 | +40% | +$4.69M |
|
6
FibroGen
FGEN
$47.8M
| $12.9M | 5.1% | 788,745 -75,000 | -9% | -$1.23M |
|
|
XLRN
7
DELISTED
Acceleron Pharma Inc.
XLRN
| $12.6M | 4.98% | 371,381 +101,092 | +37% | +$3.44M |
|
|
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $9.51M | 3.75% | +244,950 | New | +$9.51M |
|
|
DERM
9
DELISTED
Dermira, Inc.
DERM
| $7.96M | 3.14% | +272,000 | New | +$7.96M |
|
|
EPZM
10
DELISTED
Epizyme, Inc
EPZM
| $7.73M | 3.05% | 755,046 -843,854 | -53% | -$8.64M |
|
11
Kura Oncology
KURA
$686M
| $6.68M | 2.63% | 2,465,286 | – | – |
|
|
12
Intellia Therapeutics
NTLA
$1.22B
| $6.63M | 2.62% | +310,695 | New | +$6.63M |
|
|
AKAO
13
DELISTED
Achaogen, Inc.
AKAO
| $5.96M | 2.35% | +1,571,708 | New | +$5.96M |
|
|
ONC
14
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $5.23M | 2.06% | 175,380 +159,614 | +1,012% | +$4.76M |
|
|
KIN
15
DELISTED
Kindred Biosciences, Inc.
KIN
| $5.07M | 2% | 1,432,765 | – | – |
|
|
NBRV
16
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $4.22M | 1.66% | 562,741 -145,076 | -20% | -$1.09M |
|
17
Syndax Pharmaceuticals
SNDX
$1.41B
| $3.52M | 1.39% | 357,365 -153,464 | -30% | -$1.51M |
|
18
Collegium Pharmaceutical
COLL
$1.22B
| $3.34M | 1.32% | 281,776 -191,347 | -40% | -$2.27M |
|
19
Xencor
XNCR
$580M
| $3.19M | 1.26% | +168,000 | New | +$3.19M |
|
20
Enanta Pharmaceuticals
ENTA
$180M
| $3.02M | 1.19% | 136,882 -103,501 | -43% | -$2.28M |
|
21
Editas Medicine
EDIT
$231M
| $2.09M | 0.82% | 85,469 -2,452 | -3% | -$59.8K |
|
|
FWP
22
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $1.53M | 0.6% | 84,332 -12,692 | -13% | -$231K |
|
|
AKTX
23
Akari Therapeutics
AKTX
$24.8M
| $856K | 0.34% | 63,468 -28,835 | -31% | -$389K |
|
|
TSRO
24
DELISTED
TESARO, Inc.
TSRO
| $773K | 0.3% | +9,200 | New | +$773K |
|
|
ADXS
25
DELISTED
Advaxis, Inc.
ADXS
| $751K | 0.3% | +92,800 | New | +$751K |
|